Latest

2 stories

Hide weekly roundups

Thursday, August 6

Sanuwave withdraws FY2026 guidance after CMS reimbursement proposal, reports Q2 results

Sanuwave pulled its full-year outlook citing Medicare payment uncertainty as Q2 revenue fell 3% to $9.7 million and system sales dropped on reimbursement pressure and a used-equipment market.

SEC filing

Monday, July 13

Quarterly updateSANUWAVE Health, Inc

Sanuwave preliminary Q2 2026 revenue tops raised guidance range

The wound care device maker said revenue of $9.6 to $9.8 million beat the high end of its revised guidance issued in June, even as capital sales faced pressure.

SEC filing